Close
Close

Children's Hospital Los Angeles - Acute myeloid leukemia

Partner

Not provided

Rare Disease

Acute myeloid leukemia

Sponsor

Children's Hospital Los Angeles

Access Program Information

The purpose of this study is to provide expanded access to ASP2215 for a single subject with refractory FLT3-mutated AML without access to comparable or alternative therapy.

Contact

Contact: Etan Orgel, MD MS (3233612672)

Locations
  • United States
  • Los Angeles, California, United States

Free Newsletter